These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10926447

  • 21. Antimicrobial resistance patterns of respiratory pathogens: a local report from Turkey.
    Zarakolu P, Soyletir G, Gur D, Unal S.
    Clin Microbiol Infect; 2003 Dec; 9(12):1257-8. PubMed ID: 14686999
    [No Abstract] [Full Text] [Related]

  • 22. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
    Blondeau JM, Vaughan D, Laskowski R, Borsos S, Canadian Antimicrobial Study Group.
    Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615
    [Abstract] [Full Text] [Related]

  • 23. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K, Ogihara H, Ohno I, Shirato K.
    Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
    [Abstract] [Full Text] [Related]

  • 24. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
    Zarakolu P, Unal S.
    J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238
    [No Abstract] [Full Text] [Related]

  • 25. In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-1999).
    Bell JM, Turnidge JD, Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):315-8. PubMed ID: 12151193
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
    Zhang Y, Zhang F, Wang H, Zhao C, Wang Z, Cao B, Du Y, Feng X, Hu Y, Hu B, Ji P, Liu Z, Liu Y, Liao W, Lu J, Sun H, Wang Z, Xu X, Xu X, Yang Q, Yu Y, Zhang R, Zhuo C.
    J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of faropenem against respiratory pathogens.
    du Plessis M, Capper TP, Klugman KP.
    J Antimicrob Chemother; 2002 Mar; 49(3):575-7. PubMed ID: 11864964
    [No Abstract] [Full Text] [Related]

  • 28. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN.
    Clin Infect Dis; 2001 May 15; 32 Suppl 2():S81-93. PubMed ID: 11320449
    [Abstract] [Full Text] [Related]

  • 29. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF, Brown NP, Thornsberry C, Jones ME.
    Postgrad Med; 2008 Sep 15; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [Abstract] [Full Text] [Related]

  • 30. In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.
    Barry AL.
    Eur J Clin Microbiol Infect Dis; 1992 Sep 15; 11(9):867-9. PubMed ID: 1468431
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project.
    Marchese A, Debbia EA, Schito GC.
    J Antimicrob Chemother; 2000 Jul 15; 46 Suppl T1():11-5. PubMed ID: 10997594
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.
    Elshafie SS, Al-Kuwari J.
    Int J Antimicrob Agents; 2004 Sep 15; 24(3):309-10. PubMed ID: 15325441
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Hoban DJ, Zhanel GG, Karlowsky JA.
    Diagn Microbiol Infect Dis; 1999 Sep 15; 35(1):37-44. PubMed ID: 10529880
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF, Brown NP, Draghi DC, Evangelista AT, Yee YC, Thornsberry C.
    Postgrad Med; 2008 Sep 15; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.